113 related articles for article (PubMed ID: 20157398)
1. Protective effect of decursinol on mouse models of sepsis: enhancement of interleukin-10.
Jung JS; Yan JJ; Song DK
Korean J Physiol Pharmacol; 2008 Apr; 12(2):79-81. PubMed ID: 20157398
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of alpha-calcitonin gene-related peptide induces inflammatory responses and lethality in sepsis.
Lee JK; Jung JS; Park SH; Sim YB; Suh HW
Cytokine; 2013 Nov; 64(2):548-54. PubMed ID: 24021706
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of protocatechuic acid isopropyl ester against murine models of sepsis: inhibition of TNF-alpha and nitric oxide production and augmentation of IL-10.
Yan JJ; Jung JS; Hong YJ; Moon YS; Suh HW; Kim YH; Yun-Choi HS; Song DK
Biol Pharm Bull; 2004 Dec; 27(12):2024-7. PubMed ID: 15577225
[TBL] [Abstract][Full Text] [Related]
4. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
Endo Y; Kikuchi T; Nakamura M
Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
[TBL] [Abstract][Full Text] [Related]
6. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis.
Remick DG; Garg SJ; Newcomb DE; Wollenberg G; Huie TK; Bolgos GL
Crit Care Med; 1998 May; 26(5):895-904. PubMed ID: 9590320
[TBL] [Abstract][Full Text] [Related]
7. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin.
Villa P; Sartor G; Angelini M; Sironi M; Conni M; Gnocchi P; Isetta AM; Grau G; Buurman W; van Tits LJ
Clin Diagn Lab Immunol; 1995 Sep; 2(5):549-53. PubMed ID: 8548533
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
Akashi I; Kagami K; Hirano T; Oka K
J Pharm Pharmacol; 2009 Apr; 61(4):473-8. PubMed ID: 19298694
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice.
Santucci L; Fiorucci S; Chiorean M; Brunori PM; Di Matteo FM; Sidoni A; Migliorati G; Morelli A
Gastroenterology; 1996 Sep; 111(3):736-44. PubMed ID: 8780580
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect and mechanism of Ribociclib on sepsis induced-acute kidney injury].
Wang Q; Gong X; Jia J; Li G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):204-209. PubMed ID: 32275007
[TBL] [Abstract][Full Text] [Related]
11. Green tea suppresses lipopolysaccharide-induced liver injury in d-galactosamine-sensitized rats.
He P; Noda Y; Sugiyama K
J Nutr; 2001 May; 131(5):1560-7. PubMed ID: 11340116
[TBL] [Abstract][Full Text] [Related]
12. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.
Remick DG; Call DR; Ebong SJ; Newcomb DE; Nybom P; Nemzek JA; Bolgos GE
Crit Care Med; 2001 Mar; 29(3):473-81. PubMed ID: 11373406
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
15. Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (LPS)-induced high-mobility group box 1 release in vitro and improve survival of mice in LPS- and cecal ligation and puncture-induced sepsis model in vivo.
Tsoyi K; Lee TY; Lee YS; Kim HJ; Seo HG; Lee JH; Chang KC
Mol Pharmacol; 2009 Jul; 76(1):173-82. PubMed ID: 19366789
[TBL] [Abstract][Full Text] [Related]
16. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis.
Ma H; Kou J; Zhu D; Yan Y; Yu B
Int Immunopharmacol; 2006 Aug; 6(8):1355-62. PubMed ID: 16782549
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant interleukin-1 alpha protection against the lethality of endotoxin and experimental sepsis in mice.
Alexander HR; Doherty GM; Fraker DL; Block MI; Swedenborg JE; Norton JA
J Surg Res; 1991 May; 50(5):421-4. PubMed ID: 2038179
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-ethyl-1-phenyl-2-(1H) pyridone on serum biomarkers of multiorgan dysfunction and mortality in lipopolysaccharide/glactosamine and cecal ligation and puncture models of septic shock in mice.
Grattendick KJ; Nakashima JM; Giri SN
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):27-50. PubMed ID: 22032089
[TBL] [Abstract][Full Text] [Related]
19. The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice.
Libert C; Van Bladel S; Brouckaert P; Fiers W
J Immunother (1991); 1991 Aug; 10(4):227-35. PubMed ID: 1657127
[TBL] [Abstract][Full Text] [Related]
20. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
